Third Rock Ventures III L.P. 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:15 pm Unchanged | 2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Third Rock Ventures III L.P. | 2,132,867 3.600% | 0 (Unchanged) | Filing |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Third Rock Ventures III L.P. | 2,132,867 4.400% | -3,706,293 (-63.47%) | Filing |
| 2021-02-16 4:17 pm Purchase | 2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Third Rock Ventures III L.P. | 5,839,160 16.500% | 5,839,160 (New Position) | Filing |